Systemic immune responses after experimental stroke

Halina Offner; Patricia D. Hurn

doi:10.1007/978-1-4614-8915-3_10

Systemic immune responses after experimental stroke

Halina Offner, Patricia D. Hurn

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Stroke-induced pathology involves biphasic induction of an early massive peripheral immune cell activation followed by delayed, progressive splenic apoptosis and consequent immunosuppression. In this chapter, we review key immunological aspects of stroke induction and immunosuppression in the context of an emerging concept called "brain-spleen injury cycling." Moreover, we discuss the contribution to stroke severity of immune cells, including T and B cells, regulatory IL-10 secreting B cells and the programmed death receptor/ligand inhibitory pathway. Finally, we propose two novel therapeutic approaches that may limit stroke pathology and ameliorate downstream immunosuppression.

Original language	English (US)
Title of host publication	Immunological Mechanisms and Therapies in Brain Injuries and Stroke
Publisher	Springer New York
Pages	153-176
Number of pages	24
ISBN (Electronic)	9781461489153
ISBN (Print)	9781461489146
DOIs	https://doi.org/10.1007/978-1-4614-8915-3_10
State	Published - Jan 1 2014
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)
Neuroscience(all)

Access to Document

10.1007/978-1-4614-8915-3_10

Cite this

@inbook{bd5c84e79bcf4ec4886debd9df10a323,

title = "Systemic immune responses after experimental stroke",

abstract = "Stroke-induced pathology involves biphasic induction of an early massive peripheral immune cell activation followed by delayed, progressive splenic apoptosis and consequent immunosuppression. In this chapter, we review key immunological aspects of stroke induction and immunosuppression in the context of an emerging concept called {"}brain-spleen injury cycling.{"} Moreover, we discuss the contribution to stroke severity of immune cells, including T and B cells, regulatory IL-10 secreting B cells and the programmed death receptor/ligand inhibitory pathway. Finally, we propose two novel therapeutic approaches that may limit stroke pathology and ameliorate downstream immunosuppression.",

author = "Halina Offner and Hurn, {Patricia D.}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2014. All rights are reserved.",

year = "2014",

month = jan,

day = "1",

doi = "10.1007/978-1-4614-8915-3_10",

language = "English (US)",

isbn = "9781461489146",

pages = "153--176",

booktitle = "Immunological Mechanisms and Therapies in Brain Injuries and Stroke",

publisher = "Springer New York",

}

TY - CHAP

T1 - Systemic immune responses after experimental stroke

AU - Offner, Halina

AU - Hurn, Patricia D.

N1 - Publisher Copyright: © Springer Science+Business Media New York 2014. All rights are reserved.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Stroke-induced pathology involves biphasic induction of an early massive peripheral immune cell activation followed by delayed, progressive splenic apoptosis and consequent immunosuppression. In this chapter, we review key immunological aspects of stroke induction and immunosuppression in the context of an emerging concept called "brain-spleen injury cycling." Moreover, we discuss the contribution to stroke severity of immune cells, including T and B cells, regulatory IL-10 secreting B cells and the programmed death receptor/ligand inhibitory pathway. Finally, we propose two novel therapeutic approaches that may limit stroke pathology and ameliorate downstream immunosuppression.

AB - Stroke-induced pathology involves biphasic induction of an early massive peripheral immune cell activation followed by delayed, progressive splenic apoptosis and consequent immunosuppression. In this chapter, we review key immunological aspects of stroke induction and immunosuppression in the context of an emerging concept called "brain-spleen injury cycling." Moreover, we discuss the contribution to stroke severity of immune cells, including T and B cells, regulatory IL-10 secreting B cells and the programmed death receptor/ligand inhibitory pathway. Finally, we propose two novel therapeutic approaches that may limit stroke pathology and ameliorate downstream immunosuppression.

UR - http://www.scopus.com/inward/record.url?scp=85028573937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028573937&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8915-3_10

DO - 10.1007/978-1-4614-8915-3_10

M3 - Chapter

AN - SCOPUS:85028573937

SN - 9781461489146

SP - 153

EP - 176

BT - Immunological Mechanisms and Therapies in Brain Injuries and Stroke

PB - Springer New York

ER -

Systemic immune responses after experimental stroke

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this